×
0.0282958199356913 0.0282958199356913 0.0282958199356913 0.0282958199356913 -0.0128617363344052 -0.0250803858520901 0.00707395498392279 0.042443729903537
Stockreport

Kalvista Pharmaceuticals reports Q1 results [Seeking Alpha]

KALVISTA PHARMACEUTICALS (KALV)  More Company Research Source: Seeking Alpha
Last kalvista pharmaceuticals earnings: 9/14 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.kalvista.com
PDF Kalvista Pharmaceuticals ( KALV ) Q1 results : Revenues: $3.7M. Net Loss: ($5M) (-2.0%); Loss Per Share: ($0.47) (+7.8%); Quick Assets: $48.1M (-5.9%); CF Ops: ($6.2M) (-40.9%). Intravitreal Diabetic Macular Edema candidate KVD001 enrollment on track with data expected in H2 2019. Click to subscribe to real-time analytics on KALV Now read: Fennec Pharmaceuticals: NDA Submission Will Be A Major Catalyst » Subscribe for full text news in your inbox [Read more]

IMPACT SNAPSHOT EVENT TIME: KALV
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
KALV alerts
from News Quantified
Opt-in for
KALV alerts

from News Quantified
Opt-in for
KALV alerts

from News Quantified